# REVIEW_REPORT — Cycle 17
_Date: 2026-05-09 · Scope: SAS-MI-014–SAS-MI-015_

## Executive Summary

- Stop-Ship: No.
- Phase 17 completed the bounded batch analyst contract and internal analyst
  memo export.
- The memo export separates scope, corpus coverage, retrieved evidence,
  deterministic metrics, interpretation, limitations, and review queue.
- Interpretive claims are validation-bound to cited retrieved document IDs or
  deterministic metric IDs.
- Memo artifacts are marked internal-only and reject customer-facing use.
- Agentic evaluation is recorded in `docs/audit/AGENTIC_EVAL.md` with Date,
  Eval Source, and first memo guard baseline.
- Local validation passes: 135 tests, 0 skipped; `ruff check src/ tests/`
  passes; `.venv/bin/pyright` passes.
- No P0, P1, or P2 findings were found.

## P0 Issues

None.

## P1 Issues

None.

## P2 Issues

| ID | Description | Files | Status |
|----|-------------|-------|--------|
| none | No P2 findings in this cycle. | - | - |

## Carry-Forward Status

| ID | Sev | Description | Status | Change |
|----|-----|-------------|--------|--------|
| none | - | No open carry-forward findings. | - | - |

## Code Review Summary

CODE review done. P0: 0, P1: 0, P2: 0.

Checked scope:

- `src/signal_sandbox/batch_analyst/memo.py`
- `tests/unit/test_analyst_memo_export.py`
- `src/signal_sandbox/batch_analyst/__init__.py`
- `src/signal_sandbox/batch_analyst/contract.py`
- `docs/pilot/BABLOS79_INTERNAL_MARKET_MEMO.md`
- `docs/audit/AGENTIC_EVAL.md`
- `docs/CODEX_PROMPT.md`

Findings: none. The scoped code contains no secrets, SQL, network calls,
runtime LLM calls, shell mutation, report publication path, ledger mutation,
market-data mutation, or customer-facing claim path. Citation validation and
internal-only validation are covered by focused tests.

## Stop-Ship Decision

No — Phase 17 is safe to archive. Phase 18 may start with `SAS-MI-016`.
